Compounding Education in US PharmD Curricula.


Journal

American journal of pharmaceutical education
ISSN: 1553-6467
Titre abrégé: Am J Pharm Educ
Pays: United States
ID NLM: 0372650

Informations de publication

Date de publication:
10 2023
Historique:
received: 29 08 2022
revised: 31 03 2023
accepted: 04 04 2023
medline: 23 10 2023
pubmed: 19 10 2023
entrez: 18 10 2023
Statut: ppublish

Résumé

To determine the extent of compounding education (CE) offered in United States (US) doctor of pharmacy curricula. A 24-item survey instrument addressing various aspects of CE was developed and validated. An email containing the link to the survey instrument was shared with instructors of compounding at 122 of 141 accredited schools and colleges of pharmacy in the US. Of these, 112 schools and colleges responded, rendering a survey response rate of 91.8%. Survey results indicate that CE is offered to a similar extent either as a required standalone course or as integrated instruction as part of a standard course. Whereas 70.8% of programs reported mostly hands-on training in CE in their curricula, there were about 11% programs that mostly offered didactic instruction in CE. Dispersed systems and semisolid formulations are the most prepared in nonsterile compounding, while proper hand washing, garbing, and gloving are the most taught techniques in sterile compounding. Compounding education is delivered principally by pharmaceutics faculty (62.3%) compared to practice faculty (32.1%). The survey determined the extent to which CE is addressed across different schools and colleges of pharmacy in the US. Although some institutions lack minimal nonsterile or sterile compounding facilities, they may improve by modeling the established programs in the country. Leadership at pharmacy institutions may need to allocate funds for CE, and support faculty who instruct in compounding.

Identifiants

pubmed: 37852686
pii: S0002-9459(23)00118-3
doi: 10.1016/j.ajpe.2023.100117
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100117

Informations de copyright

Copyright © 2023 American Association of Colleges of Pharmacy. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alamdar Hussain (A)

School of Pharmacy, American University of Health Sciences, Signal Hill, CA, USA.

Robert P Shrewsbury (RP)

Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, USA.

Ashlee Mattingly (A)

School of Pharmacy, University of Maryland, Baltimore, MD, USA.

JoLaine R Draugalis (JR)

College of Pharmacy, University of Oklahoma, Oklahoma City, OK, USA.

Mohammad T Nutan (MT)

Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX, USA.

Sami Nazzal (S)

Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX, USA.

Mohammed A Islam (MA)

School of Pharmacy, American University of Health Sciences, Signal Hill, CA, USA. Electronic address: mislam@auhs.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH